BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36805885)

  • 21. From the pathogenesis to the cure of indolent B-cell lymphoproliferative disorders associated with hepatitis C virus infection: which role for direct-acting antivirals?
    Visentini M; Fiorilli M; Casato M
    Expert Rev Hematol; 2017 Aug; 10(8):719-727. PubMed ID: 28675071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C virus (HCV) infection and lymphoproliferative disorders.
    Libra M; Gasparotto D; Gloghini A; Navolanic PM; De Re V; Carbone A
    Front Biosci; 2005 Sep; 10():2460-71. PubMed ID: 15970508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C virus and lymphoma.
    Viswanatha DS; Dogan A
    J Clin Pathol; 2007 Dec; 60(12):1378-83. PubMed ID: 18042694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term effects of the new direct antiviral agents (DAAs) therapy for HCV-related mixed cryoglobulinaemia without renal involvement: a multicentre open-label study.
    Mazzaro C; Dal Maso L; Quartuccio L; Ghersetti M; Lenzi M; Mauro E; Bond M; Casarin P; Gattei V; Crosato IM; De Vita S; Pozzato G
    Clin Exp Rheumatol; 2018; 36 Suppl 111(2):107-114. PubMed ID: 29465371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transfusion-associated TT virus co-infection in patients with hepatitis C virus is associated with type II mixed cryoglobulinemia but not with B-cell non-Hodgkin lymphoma.
    Cacoub P; Rosenthal E; Gerolami V; Hausfater P; Ghillani P; Sterkers Y; Thibault V; Khiri H; Piette JC; Halfon P
    Clin Microbiol Infect; 2003 Jan; 9(1):39-44. PubMed ID: 12691541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From hepatitis C virus infection to B-cell lymphoma.
    Couronné L; Bachy E; Roulland S; Nadel B; Davi F; Armand M; Canioni D; Michot JM; Visco C; Arcaini L; Besson C; Hermine O
    Ann Oncol; 2018 Jan; 29(1):92-100. PubMed ID: 29045541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy.
    Mazzaro C; Quartuccio L; Adinolfi LE; Roccatello D; Pozzato G; Nevola R; Tonizzo M; Gitto S; Andreone P; Gattei V
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The Current Status and Research Progress of Antiviral Therapy in HCV-Associated Lymphoma --Review].
    Sun XH; Wan S; Li ZJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Dec; 29(6):1987-1990. PubMed ID: 34893147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
    Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct-acting antiviral agents for hepatitis C virus-mixed cryoglobulinaemia: dissociated virological and haematological responses.
    Pozzato G; Mazzaro C; Artemova M; Abdurakhmanov D; Grassi G; Crosato I; Mauro E; Ghersetti M; Zorat F; Bomben R; Bulian P; Gattei V
    Br J Haematol; 2020 Dec; 191(5):775-783. PubMed ID: 32790920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-Hodgkin lymphoma and hepatitis C: where we are and what next?
    Sulyok M; Makara M; Újhelyi E; Vályi-Nagy I
    Pathol Oncol Res; 2015 Jan; 21(1):1-7. PubMed ID: 25273531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus and lymphoma.
    Paydas S
    Crit Rev Oncol Hematol; 2015 Mar; 93(3):246-56. PubMed ID: 25457774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiviral therapies for managing viral hepatitis in lymphoma patients.
    Merli M; Rattotti S; Gotti M; Arcaini L
    Expert Opin Pharmacother; 2017 Mar; 18(4):363-376. PubMed ID: 28140702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C virus infection and antiviral treatment in marginal zone lymphomas.
    Arcaini L; Bruno R
    Curr Clin Pharmacol; 2010 May; 5(2):74-81. PubMed ID: 20156155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study.
    Michot JM; Canioni D; Driss H; Alric L; Cacoub P; Suarez F; Sibon D; Thieblemont C; Dupuis J; Terrier B; Feray C; Tilly H; Pol S; Leblond V; Settegrana C; Rabiega P; Barthe Y; Hendel-Chavez H; Nguyen-Khac F; Merle-Béral H; Berger F; Molina T; Charlotte F; Carrat F; Davi F; Hermine O; Besson C;
    Am J Hematol; 2015 Mar; 90(3):197-203. PubMed ID: 25417909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas.
    Merli M; Frigeni M; Alric L; Visco C; Besson C; Mannelli L; Di Rocco A; Ferrari A; Farina L; Pirisi M; Piazza F; Loustaud-Ratti V; Arcari A; Marino D; Sica A; Goldaniga M; Rusconi C; Gentile M; Cencini E; Benanti F; Rumi MG; Ferretti VV; Grossi P; Gotti M; Sciarra R; Tisi MC; Cano I; Zuccaro V; Passamonti F; Arcaini L
    Oncologist; 2019 Aug; 24(8):e720-e729. PubMed ID: 30552159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma.
    Kuniyoshi M; Nakamuta M; Sakai H; Enjoji M; Kinukawa N; Kotoh K; Fukutomi M; Yokota M; Nishi H; Iwamoto H; Uike N; Nishimura J; Inaba S; Maeda Y; Nawata H; Muta K
    J Gastroenterol Hepatol; 2001 Feb; 16(2):215-9. PubMed ID: 11207904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C Virus-Associated Non-Hodgkin Lymphomas: Biology, Epidemiology, and Treatment.
    Pozzato G; Mazzaro C; Gattei V
    Clin Liver Dis; 2017 Aug; 21(3):499-515. PubMed ID: 28689589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum-free light chain assessment in hepatitis C virus-related lymphoproliferative disorders.
    Terrier B; Sène D; Saadoun D; Ghillani-Dalbin P; Thibault V; Delluc A; Piette JC; Cacoub P
    Ann Rheum Dis; 2009 Jan; 68(1):89-93. PubMed ID: 18375535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The anti-lymphoma activity of antiviral therapy in HCV-associated B-cell non-Hodgkin lymphomas: a meta-analysis.
    Peveling-Oberhag J; Arcaini L; Bankov K; Zeuzem S; Herrmann E
    J Viral Hepat; 2016 Jul; 23(7):536-44. PubMed ID: 26924533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.